By HotStockRockets | Saturday 9 April 2016
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
A bloke in the City said that although results from Optibiotix's (OPTI) trials of its capsular supplement to reduce cholesterol looked great he was so fat that he was beyond redemption. Maybe. But for others results were startling. There is a caveat:
The twelve week double blind placebo controlled study recruited fifty volunteers and was designed to establish safety, compliance, and the extent of the cholesterol lowering potential of OptiBiotix's Lactobacillus plantarum strain in mildly hypercholesterolaemic adults.
50 is not a large study, bigger studies are needed. But the results on the small study were awesome. In Optibiotix's own words:
When volunteers taking placebo were compared to those taking OptiBiotix's capsular supplement the results showed a:-
· 7.2% reduction in LDL cholesterol (bad cholesterol) averaged across the whole test group
· 12.4% reduction in LDL cholesterol in females volunteers
· 15% reduction in the 50-55 age groups (both sexes)
· 36.7% reduction in volunteers' who had total cholesterol levels higher than 6mmol/L
· A 6mmHg (5.1%) reduction in systolic blood pressure averaged across the OptiBiotix group
No safety, compliance, or tolerance issues were reported by volunteers during the study in either group.
Remember this is not a pharmaceutical and thus it is cheap and it appears to work. To quote the company :
These results suggest efficacy across all volunteers similar or greater to 1.5 - 2.4 g plant sterols/stanols per day, and in volunteers with total cholesterol level greater than 6mmol/L an efficacy more typically associated with pharmaceuticals.
Back to us: This looks like it could have massive commercial potential with early deals with food companies very much on the cards. The shares are now 78-80p and at 80p or below are a strong buy ahead of results which are imminent
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |